VSTM
Verastem
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
VSTM Profile
Verastem, Inc.
A company that developing small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics
117 Kendrick Street
, Suite 500
, Needham
, Massachusetts 02494
--
Verastem, Inc., was incorporated as a Delaware corporation on August 4, 2010. The company is a late-stage biopharmaceutical company that is conducting registration-oriented trials to advance new drugs for patients battling cancer. The company's pipeline focuses on novel anticancer agents that inhibit key signaling pathways in cancer that promote cancer cell survival and tumor growth, specifically RAF/MEK inhibition and FAK inhibition.